基本信息:
- 专利标题： 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
- 专利标题（英）：Chewable tablet formulation comprising tadalafil or a pharmaceutically acceptable salt thereof
- 专利标题（中）：包含TADALAFIL或其药学上可接受的盐的可显示的片剂制剂
- 申请号：KR1020140064385 申请日：2014-05-28
- 公开(公告)号：KR1020150002453A 公开(公告)日：2015-01-07
- 发明人： 박형민 , 권용진 , 이승준 , 김용일 , 박재현 , 우종수
- 申请人： 한미약품 주식회사
- 申请人地址： 경기도 화성시 팔탄면 무하로 ***
- 专利权人： 한미약품 주식회사
- 当前专利权人： 한미약품 주식회사
- 当前专利权人地址： 경기도 화성시 팔탄면 무하로 ***
- 代理人： 리앤목특허법인
- 优先权： KR1020130076093 2013-06-28
- 主分类号： A61K9/20
- IPC分类号： A61K9/20 ; A61K9/16 ; A61K47/38 ; A61K47/30 ; A61K31/4985
The present invention granules of a pharmaceutically acceptable salt thereof as an active ingredient tadalafil; Granules of a certain particle size and density to be produced through a wet gongjeonghwa; Sodium starch glycolate, release at least one disintegrant is selected from carboxymethyl cellulose calcium, a group consisting of starch, alginic acid, and sodium alginate; And it provides an authoring tadalafil tablet containing pharmaceutically acceptable additives such. Tadalafil works of the present invention sterling, as well as the dissolution of tadalafil to excellent oral was my discomfort. Thus, even disintegrate in the mouth in an improved flavor and aroma no discomfort, you can chew without water there a problem in my dysphagia mouth the formulation is improved as the medication compliance of patients who do not, it may exhibit an enhanced efficacy of PDE-5 inhibitors may be useful in the treatment of erectile dysfunction and pulmonary hypertension patients.
公开/授权文献:
- KR102239291B1 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제 公开/授权日：2021-04-14
信息查询:
EspacenetIPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61K | 医用、牙科用或梳妆用的配制品 |
| ------A61K9/00 | 以特殊物理形状为特征的医药配制品 |
| --------A61K9/20 | .丸剂、锭剂或片剂 |